Litigation Details for VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. MYLAN PHARMACEUTICALS, INC. (D.N.J. 2015)
✉ Email this page to a colleague
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. MYLAN PHARMACEUTICALS, INC. (D.N.J. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-11-19 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-12-28 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Parties | MYLAN INC.; WYETH LLC | ||
| Patents | 6,559,158; 8,247,425; 8,420,663; 8,552,025; 8,822,490; 9,180,125 | ||
| Attorneys | BRYAN C. DINER; MICHAEL ANDREW HOLTMAN | ||
| Firms | Epstein Becker & Green, P.C. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. MYLAN PHARMACEUTICALS, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. MYLAN PHARMACEUTICALS, INC. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-03-05 | 227 | Stipulation | Issues to be Presented at Trial as to U.S. Patent No. 8,552,025 by PROGENICS PHARMACEUTICALS, INC., SALIX… 28 December 2020 2:15-cv-08180 830 Patent None District Court, D. New Jersey | External link to document |
| 2018-03-13 | 234 | Stipulation and Order | issues to be presented at trial as to U.S. Patent No. 8,552,025. Signed by Judge Stanley R. Chesler on 3… 28 December 2020 2:15-cv-08180 830 Patent None District Court, D. New Jersey | External link to document |
| 2018-03-29 | 261 | Motion in Limine | and described in the Wyeth patents-in-suit (U.S. Patent Nos. 8,247,425, 8,420,663, 8,822,490 and 9,180,125…related to the prior art status of International Patent Application Publication No. WO 2008/019115 (“Shah… 28 December 2020 2:15-cv-08180 830 Patent None District Court, D. New Jersey | External link to document |
| 2018-05-01 | 300 | Order on Motion for Summary Judgment | affects [sic].” U.S. Patent No. 6,559,158. Plaintiffs do not contend that the ’025 patent covers a new use…of the relevant patents. Plaintiffs’ motion concerns claim 8 of United States Patent No. 8,552,025 (the… This is a Hatch-Waxman case involving a patent dispute regarding pharmaceuticals: the complaints…(the “’025 patent”). ’ Plaintiffs move for partial summary judgment on Defendants’ affirmative… 3. “Foss ’954” (Deni Dec. Ex. 3.) U.S. Patent No. 5,972,954 covers methods of use of | External link to document |
| 2018-05-23 | 321 | Judgment | infringement of claim 8 of U.S. Patent No. 8,552,025 (“the ’025 patent”) of invalidity due to obviousness…Plaintiffs’ claims of patent infringement against Defendants as to claim 8 of the ’025 patent, and of Defendants…Defendants. WHEREAS, this is an action for patent infringement having been brought by Plaintiffs …infringement of, inter alia, claim 8 of the ’025 patent with respect to Actavis’s Abbreviated New Drug …infringement of, inter alia, claim 8 of the ’025 patent with respect to Mylan’s ANDA Nos. 208592 and 208594 | External link to document |
| 2016-02-03 | 9 | Amended Complaint | United States Patent Nos. 8,247,425 (“the ’425 patent”); 8,420,663 (“the ’663 patent”); 8,552,025 (“…. 021964, the ’425 patent, ’663 patent, ’025 patent, ’490 patent, and ’125 patent are listed in the FDA…expiration of the ’425 patent, ’663 patent, ’025 patent, ’490 patent, and the ’125 patent or such later date…expiration of the ’425 patent, ’663 patent, ’025 patent, ’490 patent, and the ’125 patent or such later date…expiration of the ’425 patent, ’663 patent, ’025 patent, ’490 patent, and the ’125 patent; 9. | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
